Opiate Treatment for Aboriginal High School Students in Ontario
|
|
|
- Anna Leonard
- 10 years ago
- Views:
Transcription
1 Opiate Treatment for Aboriginal High School Students in Ontario January CHALLENGE About 40% of the students at an Aboriginal high school in Thunder Bay Ontario (Canada) are known to be addicted to opioids due to the nonmedical use of prescription opioids These adolescents live in geographically remote, fly-in communities where opiate addiction is of a magnitude not seen elsewhere in Canada Addiction rates among those aged 15 or older are as high as 80% in some communities 2 NAN COMMUNITIES 3 1
2 THIS PRESENTATION Looks at an innovative school-based opiate treatment and maintenance program designed for and by Aboriginal people using Suboxone (buprenorphine/nalaxone) in a high school-based setting Approach to treatment using low-dose, short-term Suboxone combined with cultural, educational and spiritual supports Highlights elements that contribute to its success while acknowledging the challenges Based on an evaluation that reviewed student s medical charts and interviews with students, school administrators and health professionals involved with the program 4 DENNIS FRANKLIN CROMARTY HIGH SCHOOL Dennis Franklin Cromarty High School (DFC HS) has been operating in Thunder Bay since 2001 Offers grades 9 to 12 to 150 students from 24 remote Aboriginal communities that range in size from 150 to 2000 people A region that has seen 451 youth suicides over the past 20 years; many students have lost siblings and family to suicide Abuse of OxyContin and other opiate drugs (morphine, hydromorphone) is a major health issue with 63 of 150 high school students identified as addicted to opiate drugs in 2010; 75% are injection drug users Affected students had high rates of absenteeism due to addiction (searching for drugs) and symptoms of withdrawal (restless, irritable, no concentration, anxious, GI upset) 5 WHY SUBOXONE? Literature review (US, Australia, France) identified Suboxone as firstline treatment for adolescents; no clinical guidelines at the time in Ontario so used US guidelines for treatment Reserves have no access to methadone treatment as no pharmacies so other options needed to be identified Suboxone found to have a good safety profile, high efficacy, lower mortality risks Can be administered in a primary care setting, which is less stigmatizing than conventional methadone clinics Suitable for short-term detoxification and maintenance of adolescents and young adults Pilot Project target of 50 students to receive Suboxone treatment gave flexibility to Treatment Team to adjust protocols 6 2
3 TREATMENT PROGRAM Initially, 14-day detoxification was offered (8 days detox, 6 days tapering off Suboxone); students relapsed so extended to 22 days; also too short as relapsed due to craving Current protocol is a 30-Day Taper with Maintenance Top dose of Suboxone is 16 mg (93% of opiate receptors covered); less risk with alcohol use; safety considered; shorter wean period) Includes detoxification for 9 days at 16 mg then decrease 2 mg every 4 days and end at 6 mg at Day-30 Short-term, low-dose Maintenance protocol - usually start at 6 mg; (students were craving at 4 mg); dose lowered by 1 mg every 2 months; duration of treatment is months During school breaks Suboxone is administered at home by responsible adult 7 MULTIDISCIPLINARY TREATMENT TEAM Team comprised a Physician, Nurse Practitioner(s), Case Manager RN, Addiction target 5 intakes of 10 students each Team responsible for 4-Day Inductions, lab tests, symptom management, monitoring, change treatment plans School Nurse (Case Manager) & Addiction Counsellor (on site daily for daily care and delivery of aftercare activities Pharmacist initially did Direct Observed Therapy of Suboxone at off-site clinic/pharmacy Treatment Team have Suboxone Education Certification; Coordinator did on site observation at Centre for Addiction and Mental Health in Toronto, Ontario 8 TREATMENT PROTOCOL - I 1. History, physical exam, laboratory tests, policies and procedures given to each student prior to Suboxone administration 2. Informed Consent and Consent to be placed in Health Canada s Narcotic Monitoring program 3. Boarding Homes and teachers given information about treatment, symptoms expected and what to do in an emergency 4. Only one true allergy to buprenorphine found 5. During initial cycles, daily transportation provided to and from clinic/pharmacy found to be too disruptive to classes (missed first morning class) 9 3
4 TREATMENT PROTOCOL - II 5. Treatment Team Coordinator/Nurse Practitioner consults with Physician (Dr. Claudette Chase) or Addiction Psychiatrist Dr. Andriy Samokhvalov (treatment principles only) for unusual responses 6. Clinical Opiate Withdrawal Scale (COWS) score used before and after Suboxone administration to assess severity of withdrawal symptoms 7. Ancilliary medications given for withdrawal symptom management (Ibuprophen 600 mg, Gravol (aka Dramamine), Clonidine.2 mg and Trazadone 50 mg) 10 INNOVATIONS Treatment Team with diverse expertise and skills Cultural & Spiritual Psycho-Educational Program Group Session delivered by Elders, Social Worker, Addiction Counsellor and Recreation Therapist Focus on coping techniques, avoiding addiction triggers, stress management, motivation enhancement, healthy diversion Grief counselling major component of care and assessment of concurrent disorders Videoconferencing during summer for Aftercare focused on relapse prevention as drugs in home community so prevalent 11 POST-TREATMENT SUPPORTS Treatment Team monitors progress and deals with any relapses (access to Physician for dosage adjustments) Wholistic student services program (Social counsellors, Elders on site) Principal,Teachers, administrators and boarding homes highly involved and supportive Psychological counselling (Addiction Counsellor, Social worker and Psychologists) Chiefs in the area provide political and policy advocacy for funding and access to critical program elements (eg. coverage for Suboxone) 12 4
5 FOUNDATIONS FOR SUCCESS - I The program recognizes experiences of students (e.g. loss & grief from suicides, family disruptions, relationship issues, homesick ) Have been exposed to opiate drugs early as family members & friends are opiate addicted Students arrive in the city already addicted to opiates; their exposure to opiates range from 5 years to 8 months; low milligram use as drugs expensive (as high as $ for 80 mg OxyContin) Peer support encouraged - positive influences 13 FOUNDATIONS FOR SUCCESS - II Structured environment of school, acceptance, flexible staff, cultural supports Drug therapy accompanied by psycho-social counselling, spiritual and cultural program Wrap around support system, with access to external resources if required Sports & recreation activities as relapse potential is high (eg. after school, weekends) 14 FOUNDATIONS FOR SUCCESS - III Pilot design and professional creativity allowed program to quickly evolve in response to each cycle s outcomes Adjustments made in length of titration period Shift from Pharmacy/Clinic-based setting to all services now school-based using Direct Observed Therapy and caregivers on weekends Mandatory Counselling and group participation 15 5
6 BARRIERS TO SUCCESS Students attitudes: either just partying, minimizing addiction severity, shame about addiction Inability to cope with withdrawal symptoms during early induction as dose not controlling pain, vomiting so turned to opiates to control symptoms - usually better by Day 3 Continued association with family and friends who are still using (people they care about) The emotional burden of unresolved trauma in their lives & complex grief - suicide survivors 16 EXPERIENCING SUCCESS Regaining physical health, pursuing sports and other interests; being hopeful, personal insight Attending class, completing assignments, getting higher grades 9 graduates of 50 treated and now in college studies Peer support from others currently/formerly in program Skill and commitment of staff; non judgmental, compassionate 17 SUCCESS INDICATORS Complete abstinence may not occur first time; some students repeated treatment especially those in early intakes Students become more communicative, emotionally engaged and seek help dealing with challenges Risk reduction as a result of education; while still using, students shift from injection needle use to less risky behaviours like snorting 18 6
7 EVALUATION STATUS An External Evaluation was conducted on first 30 client files by Centre of Rural & Northern Health Research Total of 50 students treated therefore reached goal of Pilot Project 9 students graduated from high school & entered college education 5 currently in treatment One student remains drug-free after completing only the 30-Day program 19 THANK YOU! For further information, please contact: Mae Katt NP, Treatment Team Coordinator [email protected] Colleen McCreery RN Case Manager [email protected] Publication: Katt, M., Chase, C., Samokhvalov, A., Argento, E., Rehm, J., Fischer, B. (2012). Feasibility and Outcomes of a Community-Based Taper-to-Low-Dose-Maintenance Suboxone Treatment Program for Prescription Opioid Dependence in a Remote First Nations Community in Northern Ontario. Journal of Aboriginal Health, November
Northwestern Ontario Prescription Drug Abuse Treatment Program. Dr. Sharon Cirone Dr. Ashok Krishnamurthy
Northwestern Ontario Prescription Drug Abuse Treatment Program Dr. Sharon Cirone Dr. Ashok Krishnamurthy DISCLOSURE OF COMMERCIAL SUPPORT This program has received NO financial support This program has
The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office
The Federation of State Medical Boards 2013 Model Guidelines for Opioid Addiction Treatment in the Medical Office Adopted April 2013 for Consideration by State Medical Boards 2002 FSMB Model Guidelines
8/1/2014. Who We Are. BHG s Medical Mission. BHG Company Overview
Who We Are BHG s Medical Mission BHG Company Overview Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. Our treatment centers provide pharmacotherapeutic maintenance
MEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT. An Outpatient Model
MEDICALLY SUPERVISED OPIATE WITHDRAWAL FOR THE DEPENDENT PATIENT An Outpatient Model OBJECTIVE TO PRESENT A PROTOCOL FOR THE EVALUATION AND TREATMENT OF PATIENTS WHO ARE CHEMICALLY DEPENDENT ON OR SEVERLY
Copyright Notice. This document is the property of Alberta Health Services (AHS).
Copyright Notice This document is the property of Alberta Health Services (AHS). On April 1, 2009, AHS brought together 12 formerly separate health entities in the province: nine geographically based health
In 2010, approximately 8 million Americans 18 years and older were dependent on alcohol.
Vivitrol Pilot Study: SEMCA/Treatment Providers Collaborative Efforts with the treatment of Opioid Dependent Clients Hakeem Lumumba, PhD, CAADC SEMCA Scott Schadel, MSW, LMSW, CAADC HEGIRA PROGRAMS, INC.
Patients are still addicted Buprenorphine is simply a substitute for heroin or
BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module VI: Myths About the Use of Medication in Recovery Patients are still addicted Buprenorphine is simply a substitute
Opiate Abuse and Mental Illness
visited on Page 1 of 5 LEARN MORE (HTTP://WWW.NAMI.ORG/LEARN-MORE) FIND SUPPORT (HTTP://WWW.NAMI.ORG/FIND-SUPPORT) GET INVOLVED (HTTP://WWW.NAMI.ORG/GET-INVOLVED) DONATE (HTTPS://NAMI360.NAMI.ORG/EWEB/DYNAMICPAGE.ASPX?
5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279. Welcome
5317 Cherry Lawn Rd, Huntington, WV 25705 Phone: (304) 302-2078 Fax: (304) 302-0279 Welcome Welcome to Starlight Behavioral Health Opiate Dependence program. At Starlight, we believe that addiction is
Prescription Drug Abuse
Prescription Drug Abuse Introduction Most people take medicines only for the reasons their health care providers prescribe them. But millions of people around the world have used prescription drugs for
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,
ADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines - 2015
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
Objectives: Perform thorough assessment, and design and implement care plans on 12 or more seriously mentally ill addicted persons.
Addiction Psychiatry Program Site Specific Goals and Objectives Addiction Psychiatry (ADTU) Goal: By the end of the rotation fellow will acquire the knowledge, skills and attitudes required to recognize
Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians
Opioid Prescribing for Chronic Pain: Guidelines for Marin County Clinicians Although prescription pain medications are intended to improve the lives of people with pain, their increased use and misuse
Pain, Addiction & Methadone
Pain, Addiction & Methadone A CHALLENGING INTERFACE METHADONE AND SUBOXONE OPIOID SUBSTITUTION CONFERENCE Objectives 2 Explore the interface between concurrent pain and addiction. Appreciate the challenges
Frequently asked questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently asked questions What is Naltrexone? Naltrexone is a prescription drug that completely blocks the effects of all opioid drugs
How To Treat Anorexic Addiction With Medication Assisted Treatment
Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious
Evidence Based Approaches to Addiction and Mental Illness Treatment for Adults
Evidence Based Practice Continuum Guidelines The Division of Behavioral Health strongly encourages behavioral health providers in Alaska to implement evidence based practices and effective program models.
Mental Health and Addiction Services Overview
Mental Health and Addiction Services Overview CEAC 0216 January 2015 Mental Health and Addiction Services Management Team Executive Director (306) 766-7930 Manager, Rural Mental Health & Addictions (306)
Opioid Treatment Services, Office-Based Opioid Treatment
Optum 1 By United Behavioral Health U.S. Behavioral Health Plan, California Doing Business as OptumHealth Behavioral Solutions of California ( OHBS-CA ) 2015 Level of Care Guidelines Opioid Treatment Services,
Key Questions to Consider when Seeking Substance Abuse Treatment
www.ccsa.ca www.cclt.ca Frequently Asked Questions Key Questions to Consider when Seeking Substance Abuse Treatment The Canadian Centre on Substance Abuse (CCSA) has developed this document to address
The Field of Counseling. Veterans Administration one of the most honorable places to practice counseling is with the
Gainful Employment Information The Field of Counseling Job Outlook Veterans Administration one of the most honorable places to practice counseling is with the VA. Over recent years, the Veteran s Administration
IN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act
IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This
Neurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011
Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids
The Field of Counseling
Gainful Employment Information The Field of Counseling Job Outlook Veterans Administration one of the most honorable places to practice counseling is with the VA. Over recent years, the Veteran s Administration
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma
FRN Research Report January 2012: Treatment Outcomes for Opiate Addiction at La Paloma Background A growing opiate abuse epidemic has highlighted the need for effective treatment options. This study documents
Update on Buprenorphine: Induction and Ongoing Care
Update on Buprenorphine: Induction and Ongoing Care Elizabeth F. Howell, M.D., DFAPA, FASAM Department of Psychiatry, University of Utah School of Medicine North Carolina Addiction Medicine Conference
DrugFacts: Treatment Approaches for Drug Addiction
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please
MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER
MEDICAID DRUG SPENDING ON ANTI- ADDICTION MEDICATION AND OPIOID ADDICTION REFRESHER TWO PRIMARY ACCESS POINTS Pharmacy Benefit Dispensed by a Pharmacy Billed via the PBM Process (NCPCP) Oversight by Drug
TREATMENT MODALITIES. May, 2013
TREATMENT MODALITIES May, 2013 Treatment Modalities New York State Office of Alcoholism and Substance Abuse Services (NYS OASAS) regulates the addiction treatment modalities offered in New York State.
Practice Protocol. Buprenorphine Guidance Protocol
Practice Protocol Buprenorphine Guidance Protocol Developed by the Arizona Department of Health Services Division of Behavioral Health Services Effective Date: 02/23/11 Title Buprenorphine Guidance Protocol
Opiate Addiction, Pharmacological Treatment Approaches CO-OCCURRING MENTAL HEALTH DISORDERS JOSEPH A. BEBO MA, CAGS, LADC1
Opiate Addiction, Pharmacological Treatment Approaches CO-OCCURRING MENTAL HEALTH DISORDERS JOSEPH A. BEBO MA, CAGS, LADC1 Disclosure Statement Prevalence of Opioid Addiction 100 Individuals Die Every
Transportation Talbott Recovery can provide transportation from Hartsfield International Airport or from local hotels to the facility for admission.
Welcome to Talbott Recovery, recognized as a leading drug and alcohol treatment center with over 35 years of providing outstanding clinical programs. TALBOTT RECOVERY 5448 Yorktowne Drive Atlanta, GA 30349
Joel Millard, DSW, LCSW Dave Felt, LCSW
Joel Millard, DSW, LCSW Dave Felt, LCSW 1. Provide an overview of the effectiveness of medication assisted treatment, to include a discussion of the different types of medications and how they are used
Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction
Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction March 3, 2008 By: David Rinaldo, Ph.D., Managing Partner, The Avisa Group In this FAQ What medications are currently
COMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE
COMMUNITY BUPRENORPHINE PRESCRIBING IN OPIATE DEPENDENCE INTRODUCTION High dose sublingual buprenorphine (Subutex) tablets are available in the following strengths 0.4 mg, 2 mg, and 8 mg. Suboxone tablets,
A Review of the Impacts of Opiate Use in Ontario: Summary Report
A Review of the Impacts of Opiate Use in Ontario: Summary Report A Provincial Summary Report of the Impacts of the Discontinuation of Oxycontin in Ontario: January to August 2013 December 2013 This report
Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal
Assessment and Management of Opioid, Benzodiazepine, and Sedative-Hypnotic Withdrawal Roger Cicala, M. D. Assistant Medical Director Tennessee Physician s Wellness Program Step 1 Don t 1 It is legal in
THE CAUSES OF DRUG ADDICTION
1 Statistical facts associated with addiction and substance abuse are concerning, but many men and women choose to ignore the dangers. By understanding the main causes of addiction to drugs, it is possible
Buprenorphine Therapy in Addiction Treatment
Buprenorphine Therapy in Addiction Treatment Ken Roy, MD, FASAM Addiction Recovery Resources, Inc. River Oaks Hospital Tulane Department of Psychiatry www.arrno.org Like Minded Doc What is MAT? Definition
Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call the
DEPARTMENT OF PSYCHIATRY. 1153 Centre Street Boston, MA 02130
DEPARTMENT OF PSYCHIATRY 1153 Centre Street Boston, MA 02130 Who We Are Brigham and Women s Faulkner Hospital (BWFH) Department of Psychiatry is the largest clinical psychiatry site in the Brigham / Faulkner
Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
MEDICAL ASSISTANCE BULLETIN
ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical
Heroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
Appendix D. Behavioral Health Partnership. Adolescent/Adult Substance Abuse Guidelines
Appendix D Behavioral Health Partnership Adolescent/Adult Substance Abuse Guidelines Handbook for Providers 92 ASAM CRITERIA The CT BHP utilizes the ASAM PPC-2R criteria for rendering decisions regarding
Treatment of opioid use disorders
Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence
Wesley Mental Health. Drug and Alcohol Addiction Program. Wesley Hospital Ashfield. Journey together
Wesley Mental Health Drug and Alcohol Addiction Program Wesley Hospital Ashfield Journey together Mission Continuing the work of Jesus Christ in Word and deed Wesley Mission is an organisation with a long
ANCILLARY STABILIZATION AND WITHDRAWAL. The Why And How Of Stabilizing The Patient In A Comprehensive Treatment Setting
ANCILLARY STABILIZATION AND WITHDRAWAL The Why And How Of Stabilizing The Patient In A Comprehensive Treatment Setting About CASAColumbia A science-based, multidisciplinary organization Focused on transforming
Care Management Council submission date: August 2013. Contact Information
Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing
Procedure/ Revenue Code. Billing NPI Required. Rendering NPI Required. Service/Revenue Code Description. Yes No No
Procedure/ Revenue Code Service/Revenue Code Description Billing NPI Rendering NPI Attending/ Admitting NPI 0100 Inpatient Services Yes No Yes 0114 Room & Board - private psychiatric Yes No Yes 0124 Room
Opioids for Pain Treatment. Opioids for Chronic Pain and Addiction Treatment. Outline for Today. Opioids for pain treatment
Opioids for Chronic Pain and Addiction Treatment Joseph Merrill M.D., M.P.H. University of Washington February 24, 2012 Outline for Today Opioids for pain treatment Trends Problems High dose prescribing
Discontinuation: Involuntary Discharge
Discontinuation: Involuntary Discharge TYPICALLY A PROCESS NOT AN EVENT Objectives 2 Review indications for discharge. Develop a therapeutic approach, in the context of the nature of Substance Use Disorders.
ARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E
BULLETIN INTELLIGENCE Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E NDIC Within the past 2 years buprenorphine a Schedule III drug has been made available for use
Minnesota Co-occurring Mental Health & Substance Disorders Competencies:
Minnesota Co-occurring Mental Health & Substance Disorders Competencies: This document was developed by the Minnesota Department of Human Services over the course of a series of public input meetings held
Performance Standards
Performance Standards Co-Occurring Disorder Competency Performance Standards are intended to provide a foundation and serve as a tool to promote continuous quality improvement and progression toward best
General Hospital Information
Inpatient Programs General Hospital Information General Information The Melbourne Clinic is a purpose built psychiatric hospital established in 1975, intially privately owned by a group of psychiatrists
MEDICAL ASSISTANCE BULLETIN
ISSUE DATE September 4, 2015 SUBJECT EFFECTIVE DATE September 9, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments, Oral Buprenorphine Agents - Pharmacy
EPIDEMIOLOGY OF OPIATE USE
Opiate Dependence EPIDEMIOLOGY OF OPIATE USE Difficult to estimate true extent of opiate dependence Based on National Survey of Health and Mental Well Being: 1.2% sample used opiates in last 12 months
Medication is not a part of treatment.
Medication is not a part of treatment. Medication can be an effective part of treatment. Medication is used in the treatment of many diseases, including addiction. Medical decisions must be made by trained
DRUG AND ALCOHOL DETOXIFICATION: A GUIDE TO OUR SERVICES
01736 850006 www.bosencefarm.co.uk DRUG AND ALCOHOL DETOXIFICATION: A GUIDE TO OUR SERVICES An environment for change Boswyns provides medically-led drug and alcohol assessment, detoxification and stabilisation.
Substitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015
Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid
An integrated approach to addressing opiate abuse in Maine. Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009 Background Defining the problem: Opiates pain relievers (OxyContin,
SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK
National Institute on Drug Abuse SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK U.S. Department of Health and Human National Institutes of Health SEEKING DRUG ABUSE TREATMENT: KNOW WHAT TO ASK The goal
Disclosure. C.R. Sullivan, MD 1. Carl R. Sullivan, M.D. Professor and Director Addictions Program [email protected]. The West Virginia Model
West Virginia University School of Medicine BEHAVIORAL MEDICINE & PSYCHIATRY Morgantown, WV Carl R. Sullivan, M.D. Professor and Director Addictions Program [email protected] Disclosure Reckitt Benckiser
Concurrent Disorder Comprehensive Assessment: Every Interaction is an Intervention
Concurrent Disorder Comprehensive Assessment: Every Interaction is an Intervention Presented by: Kristin Falconer, Gillian Hutton & Stacey Whitman November 12, 2015 Disclosure Statement We have not received
Allyse Adams PC, LICDC Oriana House, Inc.
Allyse Adams PC, LICDC Oriana House, Inc. 98 Heroin Overdose Deaths from 1/1/2015-7/26/2015 Last year enough narcotic pain medicines were prescribed to supply 67 pills to every man, woman and child In
Opioid/Opiate Dependent Pregnant Women
Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than
Treatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy
Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,
How To Treat A Mental Illness At Riveredge Hospital
ABOUT US n Riveredge Hospital maintains the treatment philosophy of Trauma Informed Care. n Our commitment to providing the highest quality of care includes offering Animal Assisted Therapy, and Expressive
ACUTE TREATMENT SERVICES (ATS) FOR SUBSTANCE USE DISORDERS LEVEL III.7
ACUTE TREATMENT SERVICES (ATS) FOR SUBSTANCE USE DISORDERS LEVEL III.7 Providers contracted for this level of care or service are expected to comply with all requirements of these service-specific performance
Ambulatory Patient Groups (APG) Policy and Medicaid Billing Guidance OASAS Certified Outpatient Chemical Dependence Programs
Ambulatory Patient Groups (APG) Policy and Medicaid Billing Guidance OASAS Certified Outpatient Chemical Dependence Programs www.oasas.ny.gov TABLE OF CONTENTS SECTION: PAGE 1. Background and Introduction
Heroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain?
Heroin Heroin is a synthetic opiate drug that is highly addictive. It is made from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears
Treatments for drug misuse
Understanding NICE guidance Information for people who use NHS services Treatments for drug misuse NICE clinical guidelines advise the NHS on caring for people with specific conditions or diseases and
Opioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist
Opioid Addiction and Methadone: Myths and Misconceptions Nicole Nakatsu WRHA Practice Development Pharmacist Learning Objectives By the end of this presentation you should be able to: Understand how opioids
Grant House APPLICATION
Street Haven Addiction Services Grant House APPLICATION Dear applicant, We are pleased you are considering Grant House for treatment and hope in this package to provide more information about our program.
Dual Diagnosis Recovery Program The Handbook for Recovery
Dual Diagnosis Recovery Program The Handbook for Recovery Outpatient mental health and substance abuse / addictive behaviors services for adolescents, young adults, and adults Living better today and finding
Information for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call 1-800-662-HELP(4357)
THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES
THE OFFICE OF SUBSTANCE ABUSE SERVICES REQUIREMENTS FOR THE PROVISION OF RESIDENTIAL DETOXIFICATION SERVICES BY PROVIDERS FUNDED WITH DBHDS RESOURCES PURPOSE: The goal of this document is to describe the
Addiction Psychiatry Fellowship Rotation Goals & Objectives
Addiction Psychiatry Fellowship Rotation Goals & Objectives Table of Contents University Neuropsychiatric Institute (UNI) Training Site 2 Inpatient addiction psychiatry rotation.....2 Outpatient addiction
Behavioral Health Medical Necessity Criteria
Behavioral Health Medical Necessity Criteria Revised: 7/14/05 2 nd Revision: 9/14/06 3 rd Revision: 8/23/07 4 th Revision: 8/28/08; 11/20/08 5 th Revision: 8/27/09 Anthem Blue Cross and Blue Shield 2 Gannett
Use of Pharmacotherapies by Substance Abuse Treatment Facilities
Use of Pharmacotherapies by Substance Abuse Treatment Facilities Cathie E. Alderks, PhD Substance Abuse and Mental Health Services Administration Department of Health and Human Services November 2007 1
NEW HAMPSHIRE CODE OF ADMINISTRATIVE RULES. PART He-W 513 SUBSTANCE USE DISORDER (SUD) TREATMENT AND RECOVERY SUPPORT SERVICES
CHAPTER He-W 500 MEDICAL ASSISTANCE PART He-W 513 SUBSTANCE USE DISORDER (SUD) TREATMENT AND RECOVERY SUPPORT SERVICES He-W 513.01 Purpose. The purpose of this part is to establish the procedures and requirements
APPLICATION/ INFORMATION PACKAGE
APPLICATION/ INFORMATION PACKAGE We are glad that you are considering coming to LIFE Recovery. For your safety and well-being, we would like you to understand what our expectations are once you are admitted
Treatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction [NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call
Facilitating Comfort, Healing and Rejuvenation
DETOX PROGRAM Facilitating Comfort, Healing and Rejuvenation Our clean, comfortable facilities and gorgeous Palm Beach climate are the perfect place for physically vulnerable patients to complete their
SUBSTANCE ABUSE OUTPATIENT SERVICES
SUBSTANCE ABUSE OUTPATIENT SERVICES A. DEFINITION: Substance Abuse Outpatient is the provision of medical or other treatment and/or counseling to address substance abuse problems (i.e., alcohol and/or
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and
Subject: Health; food and drugs; treatment of opiate addiction. Statement of purpose: This bill proposes to require the department 6of health to
2012 Page 1 of 6 1 2 3 4 5 H.627 Introduced by Representative Pugh of South Burlington Referred to Committee on Date: Subject: Health; food and drugs; treatment of opiate addiction Statement of purpose:
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;/13;06/14;07/15 WRITTEN BY Jim Johnson Page 1 REVISED BY AUTHORIZED BY Jessica Moeller Debra Johnson I. APPLICATION: THUMB
NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT
NALTREXONE INDUCED DETOXIFICATION FROM OPIOIDS A METHOD OF ANTAGONIST INITIATED TREATMENT Opioid dependence is a devastating and frequently fatal medical condition. It is a manifestation of addictive disorder
INSTRUCTIONS AND PROTOCOLS FOR THE IMPLEMENTATION OF MEDICATION-ASSISTED TREATMENT FOR OPIOID/OPIATE DEPENDENCE
201 Mulholland Bay City, MI 48708 P 989-497-1344 F 989-497-1348 www.riverhaven-ca.org Title: MAT Protocol Original Date: March 30, 2009 Latest Revision Date: December 16, 2013 Approval/Release Date: January
